VectivBio Extraordinary General Meeting of Shareholders Appr

BASEL, Switzerland, June 26, 2023 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditi...

Related Keywords

Switzerland , Patrick Malloy , Computershare Trust Company , Ironwood Pharmaceuticals Inc , Exchange Commission , Vectivbio Holding Ag Nasdaq , Innisfree Ma Incorporated , Ironwood Pharmaceuticals , Eastern Time , Paying Agent , Information Agent , Acute Graft Versus Host Disease , Inherited Metabolic Diseases , Tender Offer Statement , Recommendation Statement , Annual Report ,